Genetic interactions among RAMP3 and SEMA3A are notable for human subjects with AD (Wang et al., 2021), whereby Ramp3 mechanistically acts as an amylin receptor and regulates clearance of amyloid from the brain to the blood as demonstrated in the Tg2576 mouse model (Mohamed et al., 2017). Here, SEMA3A is linked to Alzheimer disease.